University of Cologne

The national Network Genomic Medicine Lung Cancer is focused on facilitating molecular profiling-informed treatment to NSCLC patients across 28 partner hospitals in the country.

With reimbursement from public health insurance, the "model project" will run for at least five years and examine the utility of genomic sequencing for advanced cancer and rare disease patients.